BLOG
Workshop Summary: Fit-for-Purpose Animal Models for Tuberculosis
On 20 January 2026, the Stop TB Partnership Working Group on New TB Vaccines (WGNV) convened a virtual, discussion-driven workshop focused on fit-for-purpose animal models for tuberculosis (TB). The aim of the workshop was to critically examine how well existing animal models reflect the human spectrum of Mycobacterium tuberculosis (Mtb) infection and TB disease, and…
ECR Network Event Summary: Mentorship and Networking
On March 5, 2026, the Working Group on New TB Vaccines Early Career Researchers Network hosted an online discussion all about mentoring and networking—why they matter, and how to get better at both. Our thanks to Carly Young (South African Tuberculosis Vaccine Initiative; WGNV ECR Network Co-Chair), Elisa Nemes (SATVI), Rebecca Clark (London School of…
Summary: 2025 Working Group on New TB Vaccines Annual Open Meeting
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) held its 3rd Annual Open Meeting on 17 November 2025 in Copenhagen, Denmark, in advance of the Union World Conference on Lung Health. The meeting was part of “Innovate, Integrate, Impact: A symposium on New Tools to End TB”, organized by the Stop TB…
Summary: 2024 Working Group on New TB Vaccines Annual Meeting
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) held its second annual meeting on 12 November 2024 in Bali, Indonesia. The meeting was part of the full-day New TB Tools Summit 2024 – a collaboration between WGNV, the Stop TB Partnership’s Working Group on New Drugs and New Diagnostics Working Group,…
Insights from policy and advocacy sessions on the final day of the 7th Global Forum on TB Vaccines
Thursday, 10 October 2024 The TB Vaccine Advocacy Roadmap (TB Vax ARM) convened a discussion session on the final day of the the 7th Global Forum on TB Vaccines, exploring how to move political commitment to action to deliver new TB vaccines this decade. Moderated by Shaun Palmer, IAVI, and Carla Almeida, Brazilian TB CAB,…
Catch up on the latest TB Vax Webinar (Tuesday, 16 July 2024)
Tuesday, 16 July 2024 Check out the summary below or watch the recording and read the transcript for updates and insights from speakers on some of the latest developments in the TB vaccine field: Update on the WHO TB Vaccine Accelerator Council (Mike Frick, Treatment Action Group) Inclusion of new TB vaccines in Gavi’s Vaccine…
Reflections from the TB Vax ARM Webinar on the #Wins4TBVax
Thursday, 4 April 2024 The TB Vaccine Advocacy Roadmap (TB Vax ARM) were joined by Birgitte Giersing (WHO), Rupali Limaye (SMART4TB), Suvanand Sahu (Stop TB Partnership), and Maiko Tonini (Ministry of Health, Brazil) at the #Wins4TBVax webinar on Thursday 4 April. The #Wins4TBVax outline key advocacy goals for the field to achieve by 2026 to…
Summary: 2023 Working Group on New TB Vaccines Annual Meeting
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) held its first annual meeting on 14 November 2023. The meeting was part of a full-day New TB Tools Summit – a collaboration between WGNV, the Stop TB Partnership’s Working Group on New Drugs and New Diagnostics Working Group, TB Alliance, FIND, and IAVI…
All eyes on new TB vaccines – but what’s next after the HLM on TB?
Last month’s 78th United Nations (UN) General Assembly was a major week for global health, with back-to-back High-Level Meetings (HLMs) on Pandemic, Preparedness, and Response (PPR), Universal Health Coverage (UHC), and the second HLM on Tuberculosis (TB). This time round, TB vaccines were firmly in the spotlight – a sea change in support compared to…
Career Paths in TB Research: Technical and Academic Paths
The Working Group on New TB Vaccines (WGNV) Early Career Researcher Network (ECR Network) recently held the first two virtual discussion sessions in a series on career paths in TB research. Technical/Non-Academic Path On the 15th of February, Dr. Mike Leipold, a Research and Development Scientist at Stanford University, tackled the often-pondered question of “if…
Guest posts published on this blog reflect the views of their authors and persons interviewed and do not necessarily reflect the views of the Stop TB Partnership Working Group on New TB Vaccines.